Evaluation of serum and peritoneal fluid mannose‐binding lectin associated serine protease‐3, adipsin, properdin, and complement factor‐H levels in endometriosis patients
International Journal of Gynecology & Obstetrics · 2025
DOI: 10.1002/ijgo.16195 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Merve Didem Eşkin Tanrıverdi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Ankara Bilkent City Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Endometriosis, Ascitic Fluid, Complement Factor D, Mannose-Binding Protein-Associated Serine Proteases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Objective
Endometriosis is a chronic disease which has been reported to be associated with distorted immune mechanisms. The alternative pathway is a complement system which plays a role in immune defense. The present study aimed to evaluate whether the level of alternative complement molecules differ in women with endometriosis compared to heathy individuals.
Methods
A total of 58 women participated in this prospective research. Women with a diagnosis of endometriosis confirmed by laparoscopy ( n = 32) were compared to healthy women ( n = 26) in terms of serum adipsin, properdin, mannose‐binding lectin‐associated serine protease‐3 and complement factor‐H (CFH) levels. The peritoneal fluid samples which were taken during the endometriosis surgery were also analyzed in terms of the complement levels. The clinical and demographic data including the serum CA‐125 level and pelvic pain were also analyzed. SPSS version 23.0 was used in statistical analysis.
Results
The serum levels of adipsin and CFH were found to be significantly increased in women with endometriosis ( P = 0.027 and P = 0.040, respectively). Serum adipsin level was found to significantly correlate with serum CA‐125 level ( r = 0.320, P = 0.015), serum CFH level ( r = 0.705, P < 0.001), and degree of the pelvic pain complaint ( r = 0.326, P = 0.013). A strong, positive correlation was also observed between peritoneal fluid levels of adipsin, and CFH ( r = 0.593; P < 0.001).
Conclusion
To the best of our knowledge, the present study is the first to evaluate the alternative complement system in women with endometriosis. The current findings may be noteworthy to elucidate the possible role of the key molecules of the alternative pathway in endometriosis pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, Ankara Bilkent City Hospital, Ankara, Turkey.
- Department of Biochemistry, Ankara University Faculty of Pharmacy, Ankara, Turkey.
ORCID-Profile: Merve Didem Eşkin Tanrıverdi, Ecem Kaya Sezginer, Esin Merve Erol Koç, Özlem Moraloğlu Tekin
Zitieren
APA
Eşkin Tanrıverdi, M. D., Kaya Sezginer, E., Erol Koç, E. M., & Moraloğlu Tekin, Ö. (2025). Evaluation of serum and peritoneal fluid mannose‐binding lectin associated serine protease‐3, adipsin, properdin, and complement factor‐H levels in endometriosis patients. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.16195
Vancouver
Eşkin Tanrıverdi MD, Kaya Sezginer E, Erol Koç EM, Moraloğlu Tekin Ö. Evaluation of serum and peritoneal fluid mannose‐binding lectin associated serine protease‐3, adipsin, properdin, and complement factor‐H levels in endometriosis patients. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.16195
BibTeX
@article{EkinTanrverdi2025,
author = {Eşkin Tanrıverdi, Merve Didem and Kaya Sezginer, Ecem and Erol Koç, Esin Merve and Moraloğlu Tekin, Özlem},
title = {Evaluation of serum and peritoneal fluid mannose‐binding lectin associated serine protease‐3, adipsin, properdin, and complement factor‐H levels in endometriosis patients},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
doi = {10.1002/ijgo.16195}
}
EUVIMED